Search Results

There are 18906 results for: content related to: Is the Quality of the Patient-Provider Relationship Associated with Better Adherence and Health Outcomes for Patients with HIV?

  1. You have free access to this content
    British HIV Association guidelines for HIV-associated malignancies 2014

    HIV Medicine

    Volume 15, Issue S2, March 2014, Pages: 1–92, Writing Group, Prof Mark Bower, Dr A Palfreeman, Dr Maryam Alfa-Wali, Prof Chris Bunker, Dr Fiona Burns, Dr Duncan Churchill, Mr Simon Collins, Dr Kate Cwynarski, Dr Simon Edwards, Dr Paul Fields, Dr Kate Fife, Dr Eve Gallop-Evans, Dr Shireen Kassam, Dr Ranjababu Kulasegaram, Prof Charles Lacey, Dr Robert Marcus, Dr Sylvia Montoto, Dr Mark Nelson, Dr Tom Newsom-Davis, Dr Chloe Orkin, Ms Kate Shaw, Dr Melinda Tenant-Flowers, Dr Andrew Webb, Dr Sarah Westwell and Mr Matt Williams

    Version of Record online : 14 FEB 2014, DOI: 10.1111/hiv.12136

  2. You have free access to this content
    Effect of highly active antiretroviral therapy on survival among HIV-infected men with Kaposi sarcoma or non-Hodgkin lymphoma

    International Journal of Cancer

    Volume 98, Issue 6, 20 April 2002, Pages: 916–922, Henry K. Tam, Zuo-Feng Zhang, Lisa P. Jacobson, Joseph B. Margolick, Joan S. Chmiel, Charles Rinaldo and Roger Detels

    Version of Record online : 20 FEB 2002, DOI: 10.1002/ijc.10274

  3. You have free access to this content
    Treatment of severe or progressive Kaposi's sarcoma in HIV-infected adults

    Intervention Review

    The Cochrane Library

    Oluwatoyin F Gbabe, Charles I Okwundu, Martin Dedicoat and Esther E Freeman

    Published Online : 1 SEP 2014, DOI: 10.1002/14651858.CD003256.pub2

  4. You have free access to this content
    Impact of highly active antiretroviral therapy on the presenting features and outcome of patients with acquired immunodeficiency syndrome–related Kaposi sarcoma


    Volume 98, Issue 11, 1 December 2003, Pages: 2440–2446, Guglielmo Nasti, Ferdinando Martellotta, Massimiliano Berretta, Maurizio Mena, Marco Fasan, Giovanni Di Perri, Renato Talamini, Gabriella Pagano, Maria Montroni, Roberta Cinelli, Emanuela Vaccher, Antonella D'Arminio Monforte and Umberto Tirelli

    Version of Record online : 16 OCT 2003, DOI: 10.1002/cncr.11816

  5. Microcirculatory Vascular Dysfunction in HIV-1 Infected Patients Receiving Highly Active Antiretroviral Therapy



    Version of Record online : 3 FEB 2010, DOI: 10.1111/j.1549-8719.2010.00023.x

  6. You have free access to this content
    British HIV Association guidelines for HIV-associated malignancies 2008

    HIV Medicine

    Volume 9, Issue 6, July 2008, Pages: 336–388, M Bower, S Collins, C Cottrill, K Cwynarski, S Montoto, M Nelson, N Nwokolo, T Powles, J Stebbing, N Wales, A Webb and on behalf of the AIDS Malignancy Subcommittee

    Version of Record online : 8 JUL 2008, DOI: 10.1111/j.1468-1293.2008.00608.x

  7. Effects of long-term use of HAART on oral health status of HIV-infected subjects

    Journal of Oral Pathology & Medicine

    Volume 39, Issue 5, May 2010, Pages: 397–406, Wipawee Nittayananta, Sineepat Talungchit, Sutep Jaruratanasirikul, Kachornsakdi Silpapojakul, Panthip Chayakul, Ampaipith Nilmanat and Nannapat Pruphetkaew

    Version of Record online : 22 FEB 2010, DOI: 10.1111/j.1600-0714.2009.00875.x

  8. Highly active antiretroviral therapy (HAART) among HIV-infected drug users: a prospective cohort study of sexual risk and injecting behaviour


    Volume 101, Issue 3, March 2006, Pages: 433–440, Colette Smit, Karen Lindenburg, Ronald B. Geskus, Kees Brinkman, Roel A. Coutinho and Maria Prins

    Version of Record online : 27 FEB 2006, DOI: 10.1111/j.1360-0443.2006.01339.x

  9. You have free access to this content
    Reduced morbidity and mortality in the first year after initiating highly active anti-retroviral therapy (HAART) among Ugandan adults

    Tropical Medicine & International Health

    Volume 14, Issue 5, May 2009, Pages: 556–563, George Miiro, Jim Todd, Juliet Mpendo, Christine Watera, Paula Munderi, Susan Nakubulwa, Ismael Kaddu, Diana Rutebarika and Heiner Grosskurth

    Version of Record online : 19 MAR 2009, DOI: 10.1111/j.1365-3156.2009.02259.x

  10. The impact of methadone or buprenorphine treatment and ongoing injection on highly active antiretroviral therapy (HAART) adherence: evidence from the MANIF2000 cohort study


    Volume 103, Issue 11, November 2008, Pages: 1828–1836, Perrine Roux, M. Patrizia Carrieri, Virgine Villes, Pierre Dellamonica, Isabelle Poizot-Martin, Isabelle Ravaux and Bruno Spire

    Version of Record online : 5 SEP 2008, DOI: 10.1111/j.1360-0443.2008.02323.x

  11. You have full text access to this OnlineOpen article
    Barriers to accessing highly active antiretroviral therapy by HIV-positive women attending an antenatal clinic in a regional hospital in western Uganda

    Journal of the International AIDS Society

    Volume 13, Issue 1, January 2010, Page: 37, Putu Duff, Walter Kipp, T Cameron Wild, Tom Rubaale and Joa Okech-Ojony

    Version of Record online : 23 SEP 2010, DOI: 10.1186/1758-2652-13-37

  12. You have free access to this content
    The changing pattern of Kaposi sarcoma in patients with HIV, 1994–2003


    Volume 100, Issue 12, 15 June 2004, Pages: 2644–2654, Amanda Mocroft, Ole Kirk, Nathan Clumeck, Panaglotis Gargalianos-Kakolyris, Hanna Trocha, Nelly Chentsova, Francisco Antunes, Hans-Jürgen Stellbrink, Andrew N. Phillips and Jens D. Lundgren

    Version of Record online : 10 MAY 2004, DOI: 10.1002/cncr.20309

  13. You have free access to this content
    Poster Exhibition Abstracts

    HIV Medicine

    Volume 10, Issue s2, October 2009, Pages: 45–221,

    Version of Record online : 19 OCT 2009, DOI: 10.1111/j.1468-1293.2009.00792.x

  14. You have free access to this content
    British HIV Association guidelines for the management of HIV infection in pregnant women 2012

    HIV Medicine

    Volume 13, Issue S2, August 2012, Pages: 87–157, Dr GP Taylor, Ms P Clayden, Dr J Dhar, Mrs K Gandhi, Dr Y Gilleece, Dr K Harding, Dr P Hay, Ms J Kennedy, Dr N Low-Beer, Dr H Lyall, Dr A Palfreeman, Dr P Tookey, Dr S Welch, Dr E Wilkins and Dr A de Ruiter

    Version of Record online : 26 JUL 2012, DOI: 10.1111/j.1468-1293.2012.01030.x

  15. You have free access to this content
    Influence of highly active anti-retroviral therapy on response to treatment and survival in patients with acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma treated with cyclophosphamide, hydroxydoxorubicin, vincristine and prednisone

    British Journal of Haematology

    Volume 112, Issue 4, March 2001, Pages: 909–915, José-Tomás Navarro, Josep-Maria Ribera, Albert Oriol, Manuel Vaquero, Joan Romeu, Montserrat Batlle, Alonso Flores, Fuensanta Millá and Evarist Feliu

    Version of Record online : 20 DEC 2001, DOI: 10.1046/j.1365-2141.2001.02656.x

  16. You have free access to this content
    Impact of highly active antiretroviral therapy on the occurrence of bacteraemia in HIV-infected patients and their epidemiologic characteristics

    HIV Medicine

    Volume 4, Issue 2, April 2003, Pages: 127–132, J-L Meynard, M Guiguet, L Fonquernie, B Lefebvre, V Lalande, I Honore, M-C Meyohas and P–M Girard

    Version of Record online : 22 APR 2003, DOI: 10.1046/j.1468-1293.2003.00146.x

  17. You have free access to this content
    Influence of gender and HIV transmission group on initial highly active antiretroviral therapy prescription and treatment response

    HIV Medicine

    Volume 7, Issue 8, November 2006, Pages: 520–529, L Fardet, M Mary-Krause, I Heard, M Partisani, D Costagliola and for the French Hospital Database on HIV

    Version of Record online : 13 NOV 2006, DOI: 10.1111/j.1468-1293.2006.00414.x

  18. Immune reconstitution inflammatory syndrome after highly active antiretroviral therapy: a review

    Oral Diseases

    Volume 16, Issue 3, April 2010, Pages: 248–256, CSP Tsang and LP Samaranayake

    Version of Record online : 16 SEP 2009, DOI: 10.1111/j.1601-0825.2009.01628.x

  19. You have free access to this content
    Decreased CD95 expression on naive T cells from HIV-infected persons undergoing highly active anti-retroviral therapy (HAART) and the influence of IL-2 low dose administration

    Clinical & Experimental Immunology

    Volume 120, Issue 2, May 2000, Pages: 324–332, A. Amendola, F. Poccia, F. Martini, C. Gioia, V. Galati, M. Pierdominici, M. Marziali, F. Pandolfi, V. Colizzi, M. Piacentini, E. Girardi, G. D’Offizi and IRHAN STUDY GROUP

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1365-2249.2000.01223.x

  20. You have free access to this content
    Hospitalization risk following initiation of highly active antiretroviral therapy

    HIV Medicine

    Volume 11, Issue 5, May 2010, Pages: 289–298, SA Berry, YC Manabe, RD Moore and KA Gebo

    Version of Record online : 8 DEC 2009, DOI: 10.1111/j.1468-1293.2009.00776.x